eFFECTOR Therapeutics, Inc.
·
EFTRW
NASDAQ
·
Market ClosedFriday, May 23, 2025
Change
Financial Profile
Prev Close
$0.00
Market Cap
$2.82K
Day Range
$0.00 - $0.00
Open
$0.00
P/E Ratio
-0.0
52W Range
$0.00 - $0.00
24H Volume
$24.06
Dividend Yield
0.00%
EPS
-0.91
Income Statement
Revenue
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Revenue | $0 | $42M | $1.4M | $3.6M | $0 |
Cost of Revenue | $307K | $22M | $24K | $53K | $111K |
Gross Profit | -$307K | $20M | $1.4M | $3.5M | -$23M |
Gross Profit % | undefined | 48% | 98% | 99% | undefined |
R&D Expenses | $24M | $22M | $20M | $23M | $23M |
Cash Flow
Net Income
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Net Income | -$30M | $14M | $16M | -$23M | -$36M |
Dep. & Amort. | $307K | $160K | $24K | $53K | $111K |
Def. Tax | -$2M | -$333K | -$539K | $0 | $0 |
Stock Comp. | $646K | $499K | $8.7M | $5.3M | $4.6M |
Chg. in WC | $1.1M | -$824K | -$238K | $2.7M | $1.7M |
Balance Sheet
Cash
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
Cash | $3.4M | $15M | $50M | $8.7M | $15M |
ST Investments | $0 | $0 | $0 | $18M | $3.5M |
Cash & ST Inv. | $3.4M | $15M | $50M | $26M | $18M |
Receivables | $0 | $0 | $0 | $0 | $0 |
Inventory | $0 | $0 | -$100K | -$27K | $0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice.
- Market Cap
- $2.8K
- CEO
- Mr. Craig R. Jalbert CIRA
- Fulltime Employees
- 14
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- Exchange
- NASDAQ Capital Market
